Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Uncomplicated Plasmodium Falciparum Malaria
Interventions
DRUG

Artefenomel 800mg: piperaquine 640mg

Active, loose combination

DRUG

Artefenomel 800mg: piperaquine 960mg

Active, loose combination

DRUG

Artefenomel 800mg: piperaquine 1440mg

Active, loose combination

Trial Locations (9)

FSS 01 BP 188

Centre D'Étude Et de Recherchesur Le Paludisme Associé À La Grossesse Et À L'Enfance (Cerpage) Cerpage, Cotonou

Unknown

Centre National de Recherche et de Formation sur le paludisme (CNRFP) Ouagadougou, Kadiogo, Ouagadougou

Clinical research Unit of Nanoro (CRUN)/CMA Saint Camille de Nanoro, 11 BP 218 Ouagadougou CMS 11, Ouagadougou

Kinshasa School of Public Health, School of Medicine University of Kinshasa, Kinshasa

Centre de Recherches Medicales de Lambarene, Albert Schweitzer Hospital, Lambaréné

arielle K. Bouyou-Akotet, Department of Parasitology-Mycology and Tropical Medicine, Faculty of Medicine, Université des Sciences de la Santé, BP 4009, Libreville, Gabon, Libreville

MANHIÇA HEALTH RESEARCH CENTER, Rua 12, Vila da Manhica, Maputa,, Chefe Maputa

Tororo District Hospital, Tororo

National Institute of Malariology, Parasitology and Entomology, 245 Luong The Vinh Street, Trung van, Tu Liem, Hanoi, Vietnam, Hanoi

All Listed Sponsors
lead

Medicines for Malaria Venture

OTHER

NCT02083380 - Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria. | Biotech Hunter | Biotech Hunter